Depression - Major Depressive DisorderNCT07113548
PERSONAE - a Personalized Online Treatment of Depression
A study testing Personalized iCBT for depression and Standard iCBT in people with Depression - Major Depressive Disorder, run by Region of Southern Denmark at 1 site in Denmark.
Trial summary
The goal of this clinical trial is to determine whether a personalized online treatment for depression, delivered via an app (PERSONAE), is effective in treating mild to moderate depression in adults. The study will also assess the safety of the Monsenso app. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Depression - Major Depressive Disorder
- What is being tested?
- Personalized iCBT for depression and Standard iCBT
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 175 participants
- Where
- 1 siteDenmark
- Study dates
- 10 Jun 2025to Feb 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 18 years or older.
- Patient Health Questionnaire-9 items (PHQ-9) >4 AND <22.
- Any gender.
- Meeting the diagnostic criteria of the International Classification of Diseases and Related Health Problems 10th edition for major depressive disorder
Who cannot join
- Unable to speak and/or read Danish.
- No access to a smartphone.
- Pregnant or breastfeeding.
- Heightened suicide risk as per the PHQ-9 (item 9 >1) and Quick Inventory of Depressive Symptoms (QIDS) item 12.
- Comorbid disorders: Diagnosed substance dependence, bipolar affective disorder, psychotic illness, or obsessive-compulsive disorder.
- Not currently in therapeutic treatment for anxiety or depression.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Denmark1 site, 1 recruiting
- Recruiting
Center for Digital Psychiatry
Odense, 5000
Trine T.H. Sainte-Marie, Masters, 004542209922, trine.theresa.holmberg@rsyd.dk
Kim Mathiasen, Ph.d.
About this study
Official title: PERSONAE: a Personalized Adaptation of Stepped Care Internet-based Cognitive Behavioral Therapy for Depression - A Randomized Controlled Trial
The goal of this clinical trial is to determine whether a personalized online treatment for depression, delivered via an app (PERSONAE), is effective in treating mild to moderate depression in adults. The study will also assess the safety of the Monsenso app. The main questions it aims to answer are:
Does the PERSONAE intervention reduce depression scores compared to standard internet-based treatment for depression?
Read more
What challenges do participants experience when using the PERSONAE intervention?
Researchers will compare PERSONAE to Treatment As Usual (a standard, one-size-fits-all treatment) to evaluate whether PERSONAE is more effective in treating mild to moderate depression.
Participants will:
Complete a 12-week online treatment program based on cognitive behavioral therapy (CBT).
Undergo an intake assessment and complete weekly questionnaires.
Receive guidance from a clinical psychologist tailored to their individual needs
Read the detailed description
Prevalence and cost of depression
Depression is a highly prevalent disorder in Europe (Alonso et al., 2004). Globally, 280 million are estimated to suffer from depression. In Denmark, 13.2% of the population suffers from depression. The cost of affective disorders in Europe was estimated to be 106 billion euros in 2004. In Denmark, the health board's newest estimates of the cost of depression are 6700 deaths a year, 10 billion DKK for treatment, and 25 billion DKK in lost productivity. Depression has been found to cause 1124 quality-adjusted life years (QALY) lost per 100,000 patients, and compared with the general population, patients with mental disorders experience one standard deviation of lower quality of life.
Although depression is highly prevalent both in Denmark and internationally, not enough individuals with depression receive the help they need. There are barriers that can discourage help-seeking behavior. Some of the most important barriers to help-seeking behavior in Denmark are the high costs of psychotherapy as the service costs the patient pays 40% of the costs of the consultations, even after referral, and long waiting lists for being seen at a private practice psychologist. The stigma associated with mental illness, limited number of trained clinicians, and limited access to low-threshold, low-cost, and evidence-based psychotherapy furthermore present significant barriers. Several researchers have recommended further study of the implementation and dissemination of evidence-based psychotherapies.
Cognitive behavioral therapy
Cognitive behavioral therapy - one of the most used and evidence-based forms of therapy - is a combination of behavioral and cognitive therapy. Behavioral therapy was developed in the 1930's and -40's based on the research by e.g. Skinner, Pavlov, and Watson. The underlying assumption is that the patient repeats conditioned dysfunctional behaviors, which can become extinct or counteracted by behavioral exercises e.g. behavioral activation. Cognitive therapy was originally developed by Aaron Beck and is based on observations of occurrences of cognitive distortions or thought patterns that are not realistic or verifiable, leading to the conclusion that thoughts are the cause of depression. Maladaptive assumptions (thoughts) result in maladaptive behavior strategies and the development of maintenance behavior. According to Beck, cognitive distortions are a common trait in all mental disorders, and the treatment should therefore target distortions, thereby enabling awareness and realistic appraisals.
Today, behavioral and cognitive methods are combined and referred to as Cognitive Behavioral Therapy (CBT), which is often denoted second wave CBT. CBT employs both behavioral interventions and working with cognitive distortions.
CBT has been shown to be a clinically- and cost-effective treatment for depression. CBT demonstrates results equal to antidepressant pharmacotherapy and compared with pharmacotherapy only has a longer lasting effect and higher acceptability.
However, CBT still has some shortcomings, such as lack of focus on contextual influences on the patient, lack of focus on accepting negative thoughts that are not distorted, and lack of focus on emotions and emotion regulation. These shortcomings have given rise to a third wave of CBT.
This third-wave CBT consists of several different approaches, each of which tries to cover some of the lack in second-wave CBT. For example, another approach is Acceptance and Commitment Therapy (ACT), which contextualizes a person's situation, and instead of focusing only on distorted thoughts, the focus on acceptance and diffusion from thoughts and emotion is heightened compared to core CBT. Compassion focused therapy (CFT) is based on an evolutionary framework assuming humans are social beings with pro-social behavior that evolved to enhance in-group cohesion. CFT focuses on enhancing the innate compassionate and altruistic abilities towards the depressed person themselves. The purpose is to overcome the base fear and threat modes such as the inner critical voice. CFT as a tool in depression treatment is focused on shame and guilt and can especially aid people who have had adverse childhoods or other shame-inducing experiences. Positive Affect Treatment (PAT) is designed to address the symptom of anhedonia common in depression. Traditional therapies primarily focus on reducing negative emotions, whereas PAT directly targets deficits in the brain's reward system.
Internet-based self-guided, guided, and blended cognitive behavioral therapy
Over the course of the past two decades, researchers have investigated the possibility of delivering CBT via the internet in a guided self-help format named Internet-based Cognitive Behavioral Therapy (iCBT). The main part of the therapy is delivered in a self-help format through an internet-based computer program. These programs use the same therapeutic interventions, as face-to-face therapy formats; however, the content is adapted for delivery via a web platform largely designed to function as self-help. Since iCBT is still based on evidence-based CBT methods, it is not a new treatment in the classical sense, but rather a different treatment delivery format. The temporal structure also largely mimics face-to-face therapy, so patients typically go through one module in the program per week, after which they are given homework assignments, which they are expected to work on for about a week. Hereafter, they log back into the program again and take the next module, and so on. These programs typically contain 6-10 modules typically taken over approximately three months. However, there is great variation in how many modules are taken. The content of the modules are psychoeducation and exercises delivered via a variety of multimedia elements, e.g. video- and audio clips, text passages, graphics, animations, etc. Several meta-analyses have shown this treatment format to be efficacious for depression - particularly when the patients are assessed for eligibility prior to engaging with the programs and are supported by a clinician with even a minimal level of support. The support is usually comprised of approximately 10-20 minutes per week via either telephone or a secure email-like text medium built into the digital platform delivering the treatment content.
However, guided iCBT only targets a specific group of depressed patients. People with low or high symptom severity may be excluded from treatment as well as conditions with complications such as comorbidities (e.g. anxiety) or social problems interfering with the therapy. To embrace a larger demographic, earlier or stabilizing interventions or the possibility of more contact with a clinician should target these demographics. This can be achieved by including two additional treatment delivery formats: self-guided iCBT (S-iCBT) and blended iCBT (B-iCBT).
Self-guided denotes the fact that there is no actual clinician contact, and the main therapeutic alliance is formed with the program itself. There can be technical support, phone support with non-clinical staff, or no support at all. S-iCBT is effective in treating sub-threshold and mild depression. Moreover, S-iCBT has been demonstrated to be less harmful than a waitlist condition, indicating that self-guided programs are safer than no treatment. This is an important point considering that many patients are currently untreated, and a this unmet need could potentially be addressed by a cost-efficient and low-barrier service, such as self-guidet iCBT.
Patients suffering from more severe depression or comorbid disorders may need more clinician contact and support. This is especially true of those at risk of dropping out of treatment. In these cases, blended care iCBT (B-iCBT) can be employed. This type of iCBT consists of a mix of video/face-to-face consultations with a clinician and online exercises in a digital program. This format was tested in a randomized study on the clinical effectiveness of B-iCBT and was compared to face-to-face CBT for depression. In this study, it was found that although the blended condition only received half the consultations as the face-to-face condition, attrition rates and effects of treatment were similar in the two conditions. In a large-scale EU study, e-Compared, the effectiveness of B-iCBT was comparable to or better than face-to-face treatment. These two studies indicate effectiveness of B-CBT, in a patient population with moderate to severe symptom levels compared to treatment as usual in primary and secondary care.
The heterogeneous nature of depression
Symptoms of depression include rumination, guilt and shame, sleep problems, depressed mood, anhedonia, concentration difficulties, low energy/fatigue, agitation/inhibition, weight changes and suicidal ideations.
Per the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) there are 256 different combinations of symptoms that will lead to a diagnosis of depression, some of which are opposites (sleeping too much or too little or gaining or losing weight). Unipolar depression can be further divided into subtypes such as melancholic, seasonal, anxious, psychotic or atypical and they have varying characteristics such as onset, severity and recurrence. The same person can also experience different types of depression across a lifespan. Based on this heterogeneous nature, personalized treatment for depression is warranted. The problem is that iCBT for depression as it has been offered until now, is a very inflexible treatment that is often delivered as a "one-size-fits-all" approach to therapy. One approach to overcome this problem with iCBT is to engage in a care model, which adapts to the patient's needs regarding treatment intensity (self-guided, guided, or blended care) and to personalize the content based on each person's manifestation of depression.
Drop-out rates and predictors of adherence
Drop-out rates in iCBT vary widely in different conditions. A meta-analysis from 2012 found that in a completely self-guided setting, the drop-out rate was 74%. With administrative support, the drop-out rate decreased to 38%, and with non-clinical staff supporting treatment, it decreased to 28%. In a meta-analysis from Karyotaki et al., 2015, predictors for drop-out in guided iCBT were found to be male gender, lower educational level, and younger age. Furthermore, patients reported that drop-out could be caused by interference from external parameters that exist apart from the treatment itself, e.g., relationship problems and work scheduling issues, or from internal factors such as dissatisfaction with treatment allocation, time constrains, lack of treatment effect, not understanding how the programs work, or technical issues. Interestingly, some patients dropout because their condition improves. Higher rates of drop-out have also been found in people low in neuroticism and high in openness to experience. Conversely, extroversion and patients' ability to acquire new skills has been associated with completion. Importantly, it has been found that patients are more likely to stay committed to treatment if the treatment is experienced as meaningful for them and fosters motivation.
Dose dependent effect
Earlier evidence from traditional psychotherapy suggests that 11-13 sessions are needed for participants to have received adequate treatment and attain an effect on mental health problems. In the newer literature discussing iCBT and the effectiveness of CBT in general, an adequate dose is used to describe the saturation where participants have received enough treatment for it to work and last. The dose is often designated as 75% of the planned treatment or eight sessions.
Motivation for treatment
When learning new skills, such as when children start learning mathematics or languages, it is generally assumed that starting with small steps is the best approach. Children start learning at a simple level and move up in complexity by staying in the zone of proximal development. The zone of proximal development was defined by Vygotsky as the next step for learning new skills, with the help from adults or, more relevant for psychotherapy, more capable peers. This stepwise rise in complexity grants you experiences of success, which, in turn, fosters intrinsic motivation. Today this method has been augmented and is better known as scaffolding. Psychotherapy, especially CBT, can be compared to learning new skills as a clinician enables patients to understand and change dysfunctional learned and innate behavior through the patients' process of change and identification. Therefore, if depression treatment is scaled based on the level the participant is currently able to understand and profit from, it could provide more experiences of success and enable more autonomy, relatedness and experience of competency.
To increase adherence and effect of the treatment, the treatment has been developed to be meaningful for the individual patient, to target heterogenuity of depression and designed to be self-guidet, guidet and blended depending on the individual need of participants.
- Conditions
- Depression - Major Depressive Disorder
- Being tested
- Personalized iCBT for depression, Standard iCBT
- Keywords
- Depression, iCBT, randomized controlled trial, personalized, stepped-care, internet-based
- Medical subject headings
- Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Personalized iCBT for depressionBehavioural
Participants receive 12 sessions of personalized treatment in an online iCBT program. The treatment includes the option for weekly written feedback from a psychologist, or video-based interventions depending on the participant's current status. The content of the 12-week program is tailored to the participant's individual symptom profile.
The treatment incorporates elements from standard Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), Compassion-Focused Therapy (CFT), and Positive Activity Interventions (PAT).
The program consists of nine modules, each targeting a specific area:
Rumination,
Anhedonia,
Tearfulness and emotional regulation,
Sleep problems,
Difficulty concentrating,
Eating issues,
Low energy,
Social withdrawal,
Self-critical thinking,
The treatment concludes with support aimed at preventing relapse.
Standard iCBTBehavioural
Standard iCBT consisting of a "one size fits all"" progression of cognitive behavioral therapy over 12 weeks. This includes:
Introduction to Online Cognitive Behavioral Therapy
Start of Treatment
Rumination
Activity Monitoring
Activity Planning
Cognitive Restructuring
Behavioral Experiment I
Behavioral Experiment II
Core Beliefs I
Core Beliefs II
Relapse Prevention
| Study group | Role | What they receive |
|---|---|---|
| PERSONAE | Experimental | Personalized treatment arm Receives: Behavioral: Personalized iCBT for depression |
| Treatment As Usual | Active comparator | Standard iCBT Receives: Behavioral: Standard iCBT |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change from baseline in the mean depression score on the 9-item Patient Health Questionnaire (PHQ-9).
The Patient Health Questionnaire-9 (PHQ-9) has a total score range of 0-27, with higher scores indicating more severe depressive symptoms. The questionnaire will be administered via automated REDCap surveys at baseline, post-treatment, and at 3-, 6-, and 12-month follow-ups, as well as during treatment through the Minddistrict (TAU) and Monsenso (PERSONAE) programs. The PHQ-9 evaluates nine core symptoms of depression.
Measured: From enrollment to 12 weeks of treatment, plus follow up at 3, 6, and 12 months
Secondary outcomes (1)
Adherence rates
Adherence will be measured as a binary outcome, defined by whether participants have completed at least 75% of the designated treatment content or have been active for at least 75% of the allotted treatment period.
Measured: This will be assessed at the individual patient level, once the patient is no longer active in treatment-either due to completing the 12-week program or discontinuing active engagement with the intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Aug 2025
- Study start10 Jun 2025
- Primary completionOct 2026 (estimated)
- Study completionFeb 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (52)Papers the sponsor has linked to this study.
- Other trials for Depression - Major Depressive DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 175 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Region of Southern Denmark
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kim Mathiasen, University of Aarhus
- Investigators
- Kim Mathiasen, Ph.d., Principal investigator, University of Southern Denmark & Aarhus University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07113548
- Sponsor's protocol ID
- CIV-25-01-050494
- Other IDs
- 2077-00009B
- Status last verified
- Aug 2025
- First submitted
- 12 Jun 2025
- Last updated
- 15 Aug 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: After the study period, de-identified data will be shared with the University of Limerick to support the development of an algorithm aimed at helping clinicians identify at-risk patients, determine appropriate treatment content, and enhance screening efforts.
Publications
Videbech P, Deleuran A. The Danish Depression Database. Clin Epidemiol. 2016 Oct 25;8:475-478. doi: 10.2147/CLEP.S100298. eCollection 2016.
PubMed 27843341Andersson G, Bergstrom J, Hollandare F, Carlbring P, Kaldo V, Ekselius L. Internet-based self-help for depression: randomised controlled trial. Br J Psychiatry. 2005 Nov;187:456-61. doi: 10.1192/bjp.187.5.456.
PubMed 16260822Andrews G, Cuijpers P, Craske MG, McEvoy P, Titov N. Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis. PLoS One. 2010 Oct 13;5(10):e13196. doi: 10.1371/journal.pone.0013196.
PubMed 20967242Barney LJ, Griffiths KM, Jorm AF, Christensen H. Stigma about depression and its impact on help-seeking intentions. Aust N Z J Psychiatry. 2006 Jan;40(1):51-4. doi: 10.1080/j.1440-1614.2006.01741.x.
PubMed 16403038Brown LA, Gaudiano BA, Miller IW. Investigating the similarities and differences between practitioners of second- and third-wave cognitive-behavioral therapies. Behav Modif. 2011 Mar;35(2):187-200. doi: 10.1177/0145445510393730.
PubMed 21324946Buch AM, Liston C. Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics. Neuropsychopharmacology. 2021 Jan;46(1):156-175. doi: 10.1038/s41386-020-00789-3. Epub 2020 Aug 11.
PubMed 32781460Carlbring P, Andersson G, Cuijpers P, Riper H, Hedman-Lagerlof E. Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis. Cogn Behav Ther. 2018 Jan;47(1):1-18. doi: 10.1080/16506073.2017.1401115. Epub 2017 Dec 7.
PubMed 29215315Cuijpers P, Reijnders M, Karyotaki E, de Wit L, Ebert DD. Negative effects of psychotherapies for adult depression: A meta-analysis of deterioration rates. J Affect Disord. 2018 Oct 15;239:138-145. doi: 10.1016/j.jad.2018.05.050. Epub 2018 Jul 3.
PubMed 30005327Donkin L, Glozier N. Motivators and motivations to persist with online psychological interventions: a qualitative study of treatment completers. J Med Internet Res. 2012 Jun 22;14(3):e91. doi: 10.2196/jmir.2100.
PubMed 22743581Etzelmueller A, Vis C, Karyotaki E, Baumeister H, Titov N, Berking M, Cuijpers P, Riper H, Ebert DD. Effects of Internet-Based Cognitive Behavioral Therapy in Routine Care for Adults in Treatment for Depression and Anxiety: Systematic Review and Meta-Analysis. J Med Internet Res. 2020 Aug 31;22(8):e18100. doi: 10.2196/18100.
PubMed 32865497Folker AP, Mathiasen K, Lauridsen SM, Stenderup E, Dozeman E, Folker MP. Implementing internet-delivered cognitive behavior therapy for common mental health disorders: A comparative case study of implementation challenges perceived by therapists and managers in five European internet services. Internet Interv. 2018 Feb 6;11:60-70. doi: 10.1016/j.invent.2018.02.001. eCollection 2018 Mar.
PubMed 30135761Goldberg D. The heterogeneity of "major depression". World Psychiatry. 2011 Oct;10(3):226-8. doi: 10.1002/j.2051-5545.2011.tb00061.x. No abstract available.
PubMed 21991283Grandes G, Montoya I, Arietaleanizbeaskoa MS, Arce V, Sanchez A; MAS Group. The burden of mental disorders in primary care. Eur Psychiatry. 2011 Oct;26(7):428-35. doi: 10.1016/j.eurpsy.2010.11.002. Epub 2011 Feb 8.
PubMed 21306876Gunter RW, Whittal ML. Dissemination of cognitive-behavioral treatments for anxiety disorders: Overcoming barriers and improving patient access. Clin Psychol Rev. 2010 Mar;30(2):194-202. doi: 10.1016/j.cpr.2009.11.001. Epub 2009 Nov 10.
PubMed 19942331Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jonsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jonsson B, Olesen J; CDBE2010Study Group. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15.
PubMed 21924589
Study at a glance
From the registry record, last updated by the sponsor on 15 Aug 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- PERSONAE: a Personalized Adaptation of Stepped Care Internet-based Cognitive Behavioral Therapy for Depression - A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07113548
- Acronym / sponsor ID
- CIV-25-01-050494
- Conditions
- Depression - Major Depressive Disorder
- Keywords
- Depression, iCBT, randomized controlled trial, personalized, stepped-care, internet-based
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 175 participants (estimated)
- Lead sponsor
- Region of Southern DenmarkUniversity, hospital or other
- Study start
- 10 Jun 2025 (actual)
- Primary completion
- Oct 2026 (estimated)
- Study completion
- Feb 2027 (estimated)
- First posted
- 8 Aug 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to determine whether a personalized online treatment for depression, delivered via an app (PERSONAE), is effective in treating mild to moderate depression in adults. The study will also assess the safety of the Monsenso app. The main questions it aims to answer are:
Does the PERSONAE intervention reduce depression scores compared to standard internet-based treatment for depression?
What challenges do participants experience when using the PERSONAE intervention?
Researchers will compare PERSONAE to Treatment As Usual (a standard, one-size-fits-all treatment) to evaluate whether PERSONAE is more effective in treating mild to moderate depression.
Participants will:
Complete a 12-week online treatment program based on cognitive behavioral therapy (CBT).
Undergo an intake assessment and complete weekly questionnaires.
Receive guidance from a clinical psychologist tailored to their individual needs
Detailed description
Prevalence and cost of depression
Depression is a highly prevalent disorder in Europe (Alonso et al., 2004). Globally, 280 million are estimated to suffer from depression. In Denmark, 13.2% of the population suffers from depression. The cost of affective disorders in Europe was estimated to be 106 billion euros in 2004. In Denmark, the health board's newest estimates of the cost of depression are 6700 deaths a year, 10 billion DKK for treatment, and 25 billion DKK in lost productivity. Depression has been found to cause 1124 quality-adjusted life years (QALY) lost per 100,000 patients, and compared with the general population, patients with mental disorders experience one standard deviation of lower quality of life.
Although depression is highly prevalent both in Denmark and internationally, not enough individuals with depression receive the help they need. There are barriers that can discourage help-seeking behavior. Some of the most important barriers to help-seeking behavior in Denmark are the high costs of psychotherapy as the service costs the patient pays 40% of the costs of the consultations, even after referral, and long waiting lists for being seen at a private practice psychologist. The stigma associated with mental illness, limited number of trained clinicians, and limited access to low-threshold, low-cost, and evidence-based psychotherapy furthermore present significant barriers. Several researchers have recommended further study of the implementation and dissemination of evidence-based psychotherapies.
Cognitive behavioral therapy
Cognitive behavioral therapy - one of the most used and evidence-based forms of therapy - is a combination of behavioral and cognitive therapy. Behavioral therapy was developed in the 1930's and -40's based on the research by e.g. Skinner, Pavlov, and Watson. The underlying assumption is that the patient repeats conditioned dysfunctional behaviors, which can become extinct or counteracted by behavioral exercises e.g. behavioral activation. Cognitive therapy was originally developed by Aaron Beck and is based on observations of occurrences of cognitive distortions or thought patterns that are not realistic or verifiable, leading to the conclusion that thoughts are the cause of depression. Maladaptive assumptions (thoughts) result in maladaptive behavior strategies and the development of maintenance behavior. According to Beck, cognitive distortions are a common trait in all mental disorders, and the treatment should therefore target distortions, thereby enabling awareness and realistic appraisals.
Today, behavioral and cognitive methods are combined and referred to as Cognitive Behavioral Therapy (CBT), which is often denoted second wave CBT. CBT employs both behavioral interventions and working with cognitive distortions.
CBT has been shown to be a clinically- and cost-effective treatment for depression. CBT demonstrates results equal to antidepressant pharmacotherapy and compared with pharmacotherapy only has a longer lasting effect and higher acceptability.
However, CBT still has some shortcomings, such as lack of focus on contextual influences on the patient, lack of focus on accepting negative thoughts that are not distorted, and lack of focus on emotions and emotion regulation. These shortcomings have given rise to a third wave of CBT.
This third-wave CBT consists of several different approaches, each of which tries to cover some of the lack in second-wave CBT. For example, another approach is Acceptance and Commitment Therapy (ACT), which contextualizes a person's situation, and instead of focusing only on distorted thoughts, the focus on acceptance and diffusion from thoughts and emotion is heightened compared to core CBT. Compassion focused therapy (CFT) is based on an evolutionary framework assuming humans are social beings with pro-social behavior that evolved to enhance in-group cohesion. CFT focuses on enhancing the innate compassionate and altruistic abilities towards the depressed person themselves. The purpose is to overcome the base fear and threat modes such as the inner critical voice. CFT as a tool in depression treatment is focused on shame and guilt and can especially aid people who have had adverse childhoods or other shame-inducing experiences. Positive Affect Treatment (PAT) is designed to address the symptom of anhedonia common in depression. Traditional therapies primarily focus on reducing negative emotions, whereas PAT directly targets deficits in the brain's reward system.
Internet-based self-guided, guided, and blended cognitive behavioral therapy
Over the course of the past two decades, researchers have investigated the possibility of delivering CBT via the internet in a guided self-help format named Internet-based Cognitive Behavioral Therapy (iCBT). The main part of the therapy is delivered in a self-help format through an internet-based computer program. These programs use the same therapeutic interventions, as face-to-face therapy formats; however, the content is adapted for delivery via a web platform largely designed to function as self-help. Since iCBT is still based on evidence-based CBT methods, it is not a new treatment in the classical sense, but rather a different treatment delivery format. The temporal structure also largely mimics face-to-face therapy, so patients typically go through one module in the program per week, after which they are given homework assignments, which they are expected to work on for about a week. Hereafter, they log back into the program again and take the next module, and so on. These programs typically contain 6-10 modules typically taken over approximately three months. However, there is great variation in how many modules are taken. The content of the modules are psychoeducation and exercises delivered via a variety of multimedia elements, e.g. video- and audio clips, text passages, graphics, animations, etc. Several meta-analyses have shown this treatment format to be efficacious for depression - particularly when the patients are assessed for eligibility prior to engaging with the programs and are supported by a clinician with even a minimal level of support. The support is usually comprised of approximately 10-20 minutes per week via either telephone or a secure email-like text medium built into the digital platform delivering the treatment content.
However, guided iCBT only targets a specific group of depressed patients. People with low or high symptom severity may be excluded from treatment as well as conditions with complications such as comorbidities (e.g. anxiety) or social problems interfering with the therapy. To embrace a larger demographic, earlier or stabilizing interventions or the possibility of more contact with a clinician should target these demographics. This can be achieved by including two additional treatment delivery formats: self-guided iCBT (S-iCBT) and blended iCBT (B-iCBT).
Self-guided denotes the fact that there is no actual clinician contact, and the main therapeutic alliance is formed with the program itself. There can be technical support, phone support with non-clinical staff, or no support at all. S-iCBT is effective in treating sub-threshold and mild depression. Moreover, S-iCBT has been demonstrated to be less harmful than a waitlist condition, indicating that self-guided programs are safer than no treatment. This is an important point considering that many patients are currently untreated, and a this unmet need could potentially be addressed by a cost-efficient and low-barrier service, such as self-guidet iCBT.
Patients suffering from more severe depression or comorbid disorders may need more clinician contact and support. This is especially true of those at risk of dropping out of treatment. In these cases, blended care iCBT (B-iCBT) can be employed. This type of iCBT consists of a mix of video/face-to-face consultations with a clinician and online exercises in a digital program. This format was tested in a randomized study on the clinical effectiveness of B-iCBT and was compared to face-to-face CBT for depression. In this study, it was found that although the blended condition only received half the consultations as the face-to-face condition, attrition rates and effects of treatment were similar in the two conditions. In a large-scale EU study, e-Compared, the effectiveness of B-iCBT was comparable to or better than face-to-face treatment. These two studies indicate effectiveness of B-CBT, in a patient population with moderate to severe symptom levels compared to treatment as usual in primary and secondary care.
The heterogeneous nature of depression
Symptoms of depression include rumination, guilt and shame, sleep problems, depressed mood, anhedonia, concentration difficulties, low energy/fatigue, agitation/inhibition, weight changes and suicidal ideations.
Per the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) there are 256 different combinations of symptoms that will lead to a diagnosis of depression, some of which are opposites (sleeping too much or too little or gaining or losing weight). Unipolar depression can be further divided into subtypes such as melancholic, seasonal, anxious, psychotic or atypical and they have varying characteristics such as onset, severity and recurrence. The same person can also experience different types of depression across a lifespan. Based on this heterogeneous nature, personalized treatment for depression is warranted. The problem is that iCBT for depression as it has been offered until now, is a very inflexible treatment that is often delivered as a "one-size-fits-all" approach to therapy. One approach to overcome this problem with iCBT is to engage in a care model, which adapts to the patient's needs regarding treatment intensity (self-guided, guided, or blended care) and to personalize the content based on each person's manifestation of depression.
Drop-out rates and predictors of adherence
Drop-out rates in iCBT vary widely in different conditions. A meta-analysis from 2012 found that in a completely self-guided setting, the drop-out rate was 74%. With administrative support, the drop-out rate decreased to 38%, and with non-clinical staff supporting treatment, it decreased to 28%. In a meta-analysis from Karyotaki et al., 2015, predictors for drop-out in guided iCBT were found to be male gender, lower educational level, and younger age. Furthermore, patients reported that drop-out could be caused by interference from external parameters that exist apart from the treatment itself, e.g., relationship problems and work scheduling issues, or from internal factors such as dissatisfaction with treatment allocation, time constrains, lack of treatment effect, not understanding how the programs work, or technical issues. Interestingly, some patients dropout because their condition improves. Higher rates of drop-out have also been found in people low in neuroticism and high in openness to experience. Conversely, extroversion and patients' ability to acquire new skills has been associated with completion. Importantly, it has been found that patients are more likely to stay committed to treatment if the treatment is experienced as meaningful for them and fosters motivation.
Dose dependent effect
Earlier evidence from traditional psychotherapy suggests that 11-13 sessions are needed for participants to have received adequate treatment and attain an effect on mental health problems. In the newer literature discussing iCBT and the effectiveness of CBT in general, an adequate dose is used to describe the saturation where participants have received enough treatment for it to work and last. The dose is often designated as 75% of the planned treatment or eight sessions.
Motivation for treatment
When learning new skills, such as when children start learning mathematics or languages, it is generally assumed that starting with small steps is the best approach. Children start learning at a simple level and move up in complexity by staying in the zone of proximal development. The zone of proximal development was defined by Vygotsky as the next step for learning new skills, with the help from adults or, more relevant for psychotherapy, more capable peers. This stepwise rise in complexity grants you experiences of success, which, in turn, fosters intrinsic motivation. Today this method has been augmented and is better known as scaffolding. Psychotherapy, especially CBT, can be compared to learning new skills as a clinician enables patients to understand and change dysfunctional learned and innate behavior through the patients' process of change and identification. Therefore, if depression treatment is scaled based on the level the participant is currently able to understand and profit from, it could provide more experiences of success and enable more autonomy, relatedness and experience of competency.
To increase adherence and effect of the treatment, the treatment has been developed to be meaningful for the individual patient, to target heterogenuity of depression and designed to be self-guidet, guidet and blended depending on the individual need of participants.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| PERSONAE | Experimental | Behavioral: Personalized iCBT for depressionPersonalized treatment arm |
| Treatment As Usual | Active comparator | Behavioral: Standard iCBTStandard iCBT |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- 18 years or older.
- Patient Health Questionnaire-9 items (PHQ-9) >4 AND <22.
- Any gender.
- Meeting the diagnostic criteria of the International Classification of Diseases and Related Health Problems 10th edition for major depressive disorder
Key exclusion criteria (6 listed)
- Unable to speak and/or read Danish.
- No access to a smartphone.
- Pregnant or breastfeeding.
- Heightened suicide risk as per the PHQ-9 (item 9 >1) and Quick Inventory of Depressive Symptoms (QIDS) item 12.
- Comorbid disorders: Diagnosed substance dependence, bipolar affective disorder, psychotic illness, or obsessive-compulsive disorder.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Personalized iCBT for depressionParticipants receive 12 sessions of personalized treatment in an online iCBT program. The treatment includes the option for weekly written feedback from a psychologist, or video-based interventions depending on the participant's current status. The content of the 12-week program is tailored to the participant's individual symptom profile. The treatment incorporates elements from standard Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), Compassion-Focused Therapy (CFT), and Positive Activity Interventions (PAT). The program consists of nine modules, each targeting a specific area: Rumination, Anhedonia, Tearfulness and emotional regulation, Sleep problems, Difficulty concentrating, Eating issues, Low energy, Social withdrawal, Self-critical thinking, The treatment concludes with support aimed at preventing relapse. | Behavioural | PERSONAE |
| Standard iCBTStandard iCBT consisting of a "one size fits all"" progression of cognitive behavioral therapy over 12 weeks. This includes: Introduction to Online Cognitive Behavioral Therapy Start of Treatment Rumination Activity Monitoring Activity Planning Cognitive Restructuring Behavioral Experiment I Behavioral Experiment II Core Beliefs I Core Beliefs II Relapse Prevention | Behavioural | Treatment As Usual |
Primary outcome
Change from baseline in the mean depression score on the 9-item Patient Health Questionnaire (PHQ-9).
Time frame: From enrollment to 12 weeks of treatment, plus follow up at 3, 6, and 12 months
The Patient Health Questionnaire-9 (PHQ-9) has a total score range of 0-27, with higher scores indicating more severe depressive symptoms. The questionnaire will be administered via automated REDCap surveys at baseline, post-treatment, and at 3-, 6-, and 12-month follow-ups, as well as during treatment through the Minddistrict (TAU) and Monsenso (PERSONAE) programs. The PHQ-9 evaluates nine core symptoms of depression.
1 secondary outcome
Adherence rates
Time frame: This will be assessed at the individual patient level, once the patient is no longer active in treatment-either due to completing the 12-week program or discontinuing active engagement with the intervention.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Aug 2025.
- Background: PubMed 27843341Videbech P, Deleuran A. The Danish Depression Database. Clin Epidemiol. 2016 Oct 25;8:475-478. doi: 10.2147/CLEP.S100298. eCollection 2016.
- Background: PubMed 16260822Andersson G, Bergstrom J, Hollandare F, Carlbring P, Kaldo V, Ekselius L. Internet-based self-help for depression: randomised controlled trial. Br J Psychiatry. 2005 Nov;187:456-61. doi: 10.1192/bjp.187.5.456.
- Background: PubMed 20967242Andrews G, Cuijpers P, Craske MG, McEvoy P, Titov N. Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis. PLoS One. 2010 Oct 13;5(10):e13196. doi: 10.1371/journal.pone.0013196.
- Background: PubMed 16403038Barney LJ, Griffiths KM, Jorm AF, Christensen H. Stigma about depression and its impact on help-seeking intentions. Aust N Z J Psychiatry. 2006 Jan;40(1):51-4. doi: 10.1080/j.1440-1614.2006.01741.x.
- Background: PubMed 21324946Brown LA, Gaudiano BA, Miller IW. Investigating the similarities and differences between practitioners of second- and third-wave cognitive-behavioral therapies. Behav Modif. 2011 Mar;35(2):187-200. doi: 10.1177/0145445510393730.
- Background: PubMed 32781460Buch AM, Liston C. Dissecting diagnostic heterogeneity in depression by integrating neuroimaging and genetics. Neuropsychopharmacology. 2021 Jan;46(1):156-175. doi: 10.1038/s41386-020-00789-3. Epub 2020 Aug 11.
- Background: PubMed 29215315Carlbring P, Andersson G, Cuijpers P, Riper H, Hedman-Lagerlof E. Internet-based vs. face-to-face cognitive behavior therapy for psychiatric and somatic disorders: an updated systematic review and meta-analysis. Cogn Behav Ther. 2018 Jan;47(1):1-18. doi: 10.1080/16506073.2017.1401115. Epub 2017 Dec 7.
- Background: PubMed 30005327Cuijpers P, Reijnders M, Karyotaki E, de Wit L, Ebert DD. Negative effects of psychotherapies for adult depression: A meta-analysis of deterioration rates. J Affect Disord. 2018 Oct 15;239:138-145. doi: 10.1016/j.jad.2018.05.050. Epub 2018 Jul 3.
- Background: PubMed 22743581Donkin L, Glozier N. Motivators and motivations to persist with online psychological interventions: a qualitative study of treatment completers. J Med Internet Res. 2012 Jun 22;14(3):e91. doi: 10.2196/jmir.2100.
- Background: PubMed 32865497Etzelmueller A, Vis C, Karyotaki E, Baumeister H, Titov N, Berking M, Cuijpers P, Riper H, Ebert DD. Effects of Internet-Based Cognitive Behavioral Therapy in Routine Care for Adults in Treatment for Depression and Anxiety: Systematic Review and Meta-Analysis. J Med Internet Res. 2020 Aug 31;22(8):e18100. doi: 10.2196/18100.
- Background: PubMed 30135761Folker AP, Mathiasen K, Lauridsen SM, Stenderup E, Dozeman E, Folker MP. Implementing internet-delivered cognitive behavior therapy for common mental health disorders: A comparative case study of implementation challenges perceived by therapists and managers in five European internet services. Internet Interv. 2018 Feb 6;11:60-70. doi: 10.1016/j.invent.2018.02.001. eCollection 2018 Mar.
- Background: PubMed 21991283Goldberg D. The heterogeneity of "major depression". World Psychiatry. 2011 Oct;10(3):226-8. doi: 10.1002/j.2051-5545.2011.tb00061.x. No abstract available.
- The home page of the PERSONAE projectLink provided by the sponsor.
- Individual participant dataSharing planned: Yes. After the study period, de-identified data will be shared with the University of Limerick to support the development of an algorithm aimed at helping clinicians identify at-risk patients, determine appropriate treatment content, and enhance screening efforts.
Related trials for Depression - Major Depressive Disorder
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
RecruitingPhase 4
Biomarker-Guided Antidepressant Selection
Depression - Major Depressive Disorder, Treatment-resistant Depression (TRD)
Recruiting
Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
Major Depressive Disorder, Apathy
RecruitingObservational study
Student Precarity and Psychiatry
Depressive Disorder, Major, Generalized Anxiety Disorder
Not yet recruiting
Acute Intermittent Hypoxia Therapy for Depression
Major Depressive Disorder (MDD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Kim Mathiasen, Ph.d. principal investigator
University of Southern Denmark & Aarhus University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Personalized iCBT for depression and Standard iCBT in people with Depression - Major Depressive Disorder, run by Region of Southern Denmark at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 15 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Trine TH Sainte-Marie, ph.d. student (+ 42209922, trine.theresa.holmberg@rsyd.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change from baseline in the mean depression score on the 9-item Patient Health Questionnaire (PHQ-9). (time frame: From enrollment to 12 weeks of treatment, plus follow up at 3, 6, and 12 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07113548, which also lists 52 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Aug 2025.